Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Invitro International (IVRO)

Invitro International (IVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.42
Trade IVRO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 +36.75%
on 03/26/24
0.0551 -0.73%
on 04/11/24
+0.0029 (+5.60%)
since 03/21/24
3-Month
0.0280 +95.36%
on 03/19/24
0.0645 -15.19%
on 02/06/24
-0.0053 (-8.83%)
since 01/17/24
52-Week
0.0280 +95.36%
on 03/19/24
0.1098 -50.18%
on 05/08/23
-0.0509 (-48.20%)
since 04/20/23

Most Recent Stories

More News
InVitro International Sees Real Positives in Start to FY '24

Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies,...

IVRO : 0.0547 (+1.30%)
InVitro International Announces Fiscal Year End 2023 and Continues Positives

Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies,...

IVRO : 0.0547 (+1.30%)
IVRO Announces Fiscal Q #3 2023 Results While Continuing M&A Strategy to Make Non-Animal Testing Famous

Placentia, California--(Newsfile Corp. - August 9, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023...

IVRO : 0.0547 (+1.30%)
IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q2 2023 Results

Placentia, California--(Newsfile Corp. - May 11, 2023) - Today InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023 second...

IVRO : 0.0547 (+1.30%)
IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q1 2023 Results

Placentia, California--(Newsfile Corp. - February 8, 2023) - Today InVitro International (OTC Pink: IVRO), the 37 year pioneer developer and marketer of animal free testing methods, announced first fiscal...

IVRO : 0.0547 (+1.30%)
IVRO'S Mission To Help Make Non-Animal Testing Famous Now Searches For Strategic Partners

PLACENTIA, CA / ACCESSWIRE / September 1, 2021 / InVitro International (OTC PINK:IVRO) announced today that it has taken a first step in its search for strategic partners. IVRO entered into Letter of Intent...

IVRO : 0.0547 (+1.30%)
IVRO Pursues Mission To "Help Make Non Animal Testing Famous"; Releases FY Q3 and YTD 2021 Results

PLACENTIA, CA / ACCESSWIRE / August 4, 2021 / InVitro International (OTC PINK:IVRO) is pleased to announce FY 2021 3rd quarter revenues of $310,700 and net income of $87,644. These sales were 35%+ vs same...

IVRO : 0.0547 (+1.30%)
IVRO Continues Its Mission To "Help Make Non Animal Testing Famous"; Releases FY Q2 and YTD 2021 Results

PLACENTIA, CA / ACCESSWIRE / May 11, 2021 / InVitro International (OTC PINK:IVRO) today announced net income of $10,094 for its first six months of fiscal 2021 and a net loss of $57,704 in the 2nd fiscal...

IVRO : 0.0547 (+1.30%)
Invitro International, A Pioneer in Non-Animal Testing Alternatives For Ocular and Dermal Toxicity Releases FY Q1 2021 Results

PLACENTIA, CA / ACCESSWIRE / February 10, 2021 / InVitro International (OTCPINK:IVRO) is pleased to announce net income of $67,663 in its first fiscal quarter of 2021, ending December 31st, 2020. This...

IVRO : 0.0547 (+1.30%)
Invitro International, a Pioneer in Non-Animal Testing Alternatives for Ocular and Dermal Toxicity Releases FY 2020 Results

PLACENTIA, CA / ACCESSWIRE / December 8, 2020 / InVitro International (OTC PINK:IVRO), is pleased to announce revenues of $1,104,816 and net income of $49,894 for our fiscal year ending on September 30th,...

IVRO : 0.0547 (+1.30%)

Key Turning Points

3rd Resistance Point 0.0607
2nd Resistance Point 0.0573
1st Resistance Point 0.0557
Last Price 0.0547
1st Support Level 0.0507
2nd Support Level 0.0473
3rd Support Level 0.0457

See More

52-Week High 0.1098
Fibonacci 61.8% 0.0786
Fibonacci 50% 0.0689
Fibonacci 38.2% 0.0592
Last Price 0.0547
52-Week Low 0.0280

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar